Clinical trial
Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a…
NCT00248547 · OHSU Knight Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00248547 |
|---|---|
| Title | Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant |
| Official title | A Pilot Study of Aprepitant vs. Placebo Combined With Standard Antiemetics for the Control of Nausea and Vomiting During Hematopoietic Cell Transplatation(HCT) |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | aprepitant, dexamethasone, ondansetron, placebo |
| Enrollment | 40 |
| Start date | May 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Nov 4, 2005 |
| Last update posted | May 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: